Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis

Cellular and Molecular Gastroenterology and Hepatology(2022)10.1016/j.jcmgh.2022.01.009Source: DataRank Database

Cannabinoid Receptor 1 Antagonism Demonstrates High Therapeutic Potential for the Treatment of Primary Sclerosing Cholangitis is a research paper published in Cellular and Molecular Gastroenterology and Hepatology (2022). On theSindex it has a DataRank of 0.104. It has been cited 1 time, with 1 citing works in its 1-hop citation network.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

Open Access1 citations · 1 citing works in its network

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.15)OA: goldTopics (29)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

From 0 citing papers with measurable signal

This paper's DataRank is currently driven only by its base citation score. None of the citing papers had measurable citation signal.

Learn more about DataRank methodology →

Authors (2)

Gianfranco Alpini ORCID,Lindsey Kennedy ORCID

Live enrichment

PubMed:35131175 PMC:PMC9073729 OpenAlex:https://openalex.org/W4210405698

BLRD VA

Grant: I01 BX000574

BLRD VA

Grant: IK6 BX004601

BLRD VA

Grant: IK2 BX005306

National Institutes of Health

Grant: 5R01AA028711-03

Alcohol-induced hepatotoxicity - implications of secretin/secretin receptor axis

National Institutes of Health

Grant: 7R01DK054811-15

Growth Regulation of the Intrahepatic Biliary Tree

National Institutes of Health

Grant: 1IK6BX004601-01

BLR&D Research Career Scientist Award

National Institutes of Health

Grant: 2I01BX000574-09

Autocrine/Paracrine Regulation of Intrahepatic Bile Duct Growth

National Institutes of Health

Grant: 1IK2BX005306-01

Cholangiocyte-Derived Endothelin Signaling Mediates Biliary Injury and Liver Fibrosis

FWCI

0.15

Citation Percentile

0.4%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttp://www.cmghjournal.org/article/S2352345X22000091/pdf

publisherhttp://www.cmghjournal.org/article/S2352345X22000091/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2352345X22000091?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2352345X22000091?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcmgh.2022.01.009

Fields of Study

Liver Disease Diagnosis and TreatmentLiver Diseases and ImmunityLiver Disease and Transplantation0301 basic medicine03 medical and health sciencesCholangitis, SclerosingHumansReceptors, Cannabinoid

MeSH Terms

HumansCholangitis, SclerosingReceptors, Cannabinoid

Keywords

MedicineInternal medicineCannabinoid receptorPrimary sclerosing cholangitisEndocannabinoid systemGastroenterologyFibrosisCannabisHepatic fibrosisReceptorInflammationFibrogenesisEditorialCholangitis, SclerosingHumansCannabinoid receptorsReceptors, CannabinoidSclerosing cholangitis

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being